Mississippi’s medical marijuana program is still in its early stages, but it’s already impacting patients across the state. In a recent podcast, Mississippi Today’s Geoff Pender and Bobby Harrison discussed the program’s progress with Angie Calhoun, founder and CEO of the Mississippi Cannabis Patients Alliance (MCPA). Calhoun has been a vocal advocate for medical marijuana, largely driven by her own family’s experience. Her son, who suffers from severe Lyme disease, was unable to access cannabis as a treatment option in Mississippi, which led her to advocate for change.
The Mississippi Cannabis Patients Alliance: A Vital Resource for Patients
Calhoun’s Mississippi Cannabis Patients Alliance has become a crucial support network for patients and healthcare practitioners alike. The organization provides educational resources, helps patients navigate the application process, and connects them with approved medical professionals who can prescribe cannabis.
Calhoun shared that for many patients, understanding the program and accessing licensed dispensaries is still challenging. With MCPA’s resources, the group aims to make medical cannabis an accessible option for all who qualify under the state’s guidelines. The alliance’s website offers valuable information for patients and practitioners, which is crucial as the program continues to develop.
Advocating for Broader Access and Patient Support
The advocacy efforts of MCPA go beyond simply informing patients. Calhoun and her team work with policymakers to address any barriers patients face, such as the limited number of licensed dispensaries and the lengthy certification process. Since medical marijuana became legal in Mississippi, MCPA has also been active in pushing for policy adjustments to streamline access and ensure quality control.
Patients who turn to MCPA often find themselves caught in a web of regulations that can be overwhelming. By helping patients find the right physicians and learn about qualifying conditions, MCPA is taking steps to make the program more accessible and patient-focused.
Initial Patient Experiences with Mississippi’s Medical Marijuana Program
Feedback from early adopters of the program has been mixed. Many patients report significant relief, especially those managing chronic pain, seizures, and other debilitating conditions. However, some face obstacles in terms of limited supply and high costs, which Mississippi’s medical cannabis regulations still don’t fully address.
The podcast revealed that despite these challenges, patient interest is high. Calhoun hopes that as more dispensaries open, competition will help stabilize prices and improve access. The Mississippi Cannabis Patients Alliance is working to ensure patients have a voice in the program’s development, pushing for adjustments that will benefit those who rely on medical marijuana as a treatment.